戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 apeutic properties against the growth of the breast neoplasm.
2 tumorigenesis, invasion, metastasis of human breast neoplasm.
3                         Consequently, 93.3% (breast neoplasms), 90% (prostate neoplasms) and 93.3% (p
4  cotransfected with DNA from the spontaneous breast neoplasm, along with a plasmid (pHyg) conferring
5 n human diseases including Breast Neoplasms, Breast Neoplasms and Lymphoma.
6 onic for invasive lobular carcinoma (ILC) in breast neoplasms, as ground truth.
7 bility of LMTRDA in human diseases including Breast Neoplasms, Breast Neoplasms and Lymphoma.
8 it from 1966 to 1995 on the following terms: breast neoplasms; chemotherapy, adjuvant; menstruation d
9                     A detailed case study on breast neoplasms, colorectal neoplasms, lung neoplasms,
10 overview of unusual and a few rare malignant breast neoplasms, highlighting particular or specific cl
11 lure, Alzheimer's disease, arteriosclerosis, breast neoplasms, hypertension, myocardial infarction, o
12                                      Unusual breast neoplasms may be broadly divided into invasive lo
13               Keywords: Ablation Techniques, Breast, Neoplasms-Primary, Percutaneous, Tumor Microenvi
14                       Keywords: Mammography, Breast, Neoplasms-Primary, Screening, Epidemiology, Diag
15 randomized controlled Dense Tissue and Early Breast Neoplasm Screening (DENSE) trial from December 20
16                   The Dense Tissue and Early Breast Neoplasm Screening (DENSE) trial provides an oppo
17 creening round of the Dense Tissue and Early Breast Neoplasm Screening (DENSE) trial, a considerable
18 ndary analysis of the Dense Tissue and Early Breast Neoplasm Screening trial.
19 ysis of data from the Dense Tissue and Early Breast Neoplasm Screening, or DENSE, trial evaluated bre
20                   The Dense Tissue and Early Breast Neoplasm Screening, or DENSE, trial is a multicen
21              Phyllodes tumors (PTs) are rare breast neoplasms, which have little granular data on mar
22 is study was to quantify microcirculation in breast neoplasms with magnetic susceptibility-based cont